Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Bratislava Medical Journal Vol.116, No.4, p.205-211, 2016 |
||
Title: Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy | ||
Author: T. Hlavaty, A. Krajcovicova, J. Letkovsky, I. Sturdik, T. Koller, J. Toth, M. Huorka | ||
Abstract: BACKGROUND AND AIMS: Relapse rates after discontinuing anti-tumor necrosis factor-α (TNFα) therapy of inflammatory bowel disease (IBD) patients in deep remission are poorly understood. This prospective single-center open-label study evaluated the relapse rates of IBD patients after stopping anti-TNFα therapy.
|
||
Keywords: Crohn’s disease, ulcerative colitis, infliximab, adalimumab, treatment discontinuation, relapse rate | ||
Published online: 04-Apr-2016 | ||
Year: 2016, Volume: 116, Issue: 4 | Page From: 205, Page To: 211 | |
doi:10.4149/BLL_2016_039 |
||
|
download file |
|